| Primary |
| Cardiac Failure |
32.4% |
| Hyponatraemia |
11.1% |
| Fluid Retention |
10.3% |
| Inappropriate Antidiuretic Hormone Secretion |
8.3% |
| Prophylaxis |
7.6% |
| Hypertension |
5.2% |
| Cardiac Failure Congestive |
5.0% |
| Product Used For Unknown Indication |
4.6% |
| Cardiac Failure Chronic |
3.0% |
| Atrial Fibrillation |
1.7% |
| Oedema Peripheral |
1.4% |
| Pneumonia |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Thrombosis Prophylaxis |
1.1% |
| Surgery |
1.0% |
| Tumour Pain |
1.0% |
| Polyuria |
1.0% |
| Insomnia |
0.9% |
| Pain |
0.9% |
| Blood Sodium Decreased |
0.8% |
|
| Hypernatraemia |
12.3% |
| Wrong Technique In Drug Usage Process |
10.5% |
| Rapid Correction Of Hyponatraemia |
10.2% |
| Thirst |
9.3% |
| Death |
8.4% |
| Hyponatraemia |
7.0% |
| Condition Aggravated |
5.0% |
| Renal Impairment |
4.8% |
| Blood Urea Increased |
4.3% |
| Cardiac Failure |
3.6% |
| Blood Sodium Decreased |
3.4% |
| Pneumonia |
2.9% |
| Blood Sodium Increased |
2.7% |
| Drug Ineffective |
2.7% |
| Dehydration |
2.3% |
| Off Label Use |
2.3% |
| Cerebral Infarction |
2.1% |
| Interstitial Lung Disease |
2.1% |
| Platelet Count Decreased |
2.1% |
| Renal Failure Acute |
2.1% |
|
| Secondary |
| Cardiac Failure |
17.8% |
| Hypertension |
17.5% |
| Inappropriate Antidiuretic Hormone Secretion |
8.3% |
| Prophylaxis |
8.0% |
| Product Used For Unknown Indication |
6.9% |
| Atrial Fibrillation |
4.3% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Type 2 Diabetes Mellitus |
3.6% |
| Tumour Pain |
3.5% |
| Hyponatraemia |
3.4% |
| Fluid Retention |
2.9% |
| Cardiac Failure Congestive |
2.8% |
| Insomnia |
2.5% |
| Chemotherapy |
2.4% |
| Pneumonia |
2.4% |
| Thrombosis Prophylaxis |
2.1% |
| Coronary Artery Disease |
2.0% |
| Lung Neoplasm Malignant |
1.9% |
| Osteoporosis |
1.9% |
| Polyuria |
1.8% |
|
| Wrong Technique In Drug Usage Process |
43.6% |
| Renal Impairment |
7.4% |
| Pneumonia |
4.9% |
| Rapid Correction Of Hyponatraemia |
4.4% |
| Thirst |
4.4% |
| Hypernatraemia |
3.9% |
| Drug Ineffective |
3.4% |
| Urosepsis |
3.4% |
| Hypothyroidism |
2.9% |
| Off Label Use |
2.9% |
| Sepsis |
2.9% |
| White Blood Cell Count Increased |
2.5% |
| Multi-organ Failure |
2.0% |
| Platelet Count Decreased |
2.0% |
| Tachycardia |
2.0% |
| Death |
1.5% |
| Head Injury |
1.5% |
| Interstitial Lung Disease |
1.5% |
| Malignant Neoplasm Progression |
1.5% |
| Pneumonia Aspiration |
1.5% |
|
| Concomitant |
| Head And Neck Cancer |
15.3% |
| Prophylaxis |
11.5% |
| Pulmonary Arterial Hypertension |
11.5% |
| Hypertension |
7.6% |
| Product Used For Unknown Indication |
7.0% |
| Cardiac Failure Chronic |
6.4% |
| Cardiac Failure |
5.7% |
| Immune Thrombocytopenic Purpura |
5.7% |
| Insomnia |
3.8% |
| Atrial Fibrillation |
3.2% |
| Diabetes Mellitus |
3.2% |
| Fluid Retention |
2.5% |
| Non-small Cell Lung Cancer |
2.5% |
| T-cell Prolymphocytic Leukaemia |
2.5% |
| Breast Cancer |
1.9% |
| Depression |
1.9% |
| Electrolyte Substitution Therapy |
1.9% |
| Herpes Zoster |
1.9% |
| Hyperuricaemia |
1.9% |
| Osteoporosis |
1.9% |
|
| Hypoxia |
18.8% |
| Platelet Count Decreased |
15.6% |
| Blood Pressure Decreased |
9.4% |
| Pneumonia |
6.3% |
| Cardiac Failure Chronic |
3.1% |
| Cerebral Infarction |
3.1% |
| Electrocardiogram St-t Change |
3.1% |
| Interstitial Lung Disease |
3.1% |
| Jaundice |
3.1% |
| Mastitis |
3.1% |
| Multi-organ Failure |
3.1% |
| Pancytopenia |
3.1% |
| Pulmonary Haemorrhage |
3.1% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Respiratory Failure |
3.1% |
| Sepsis |
3.1% |
| Shock Haemorrhagic |
3.1% |
| Somnolence |
3.1% |
| Thrombotic Microangiopathy |
3.1% |
|
